优化特发性震颤的脑深部电刺激:一项考虑靶点的随机对照试验
这项随机双盲交叉试验在9例完成研究的药物难治性特发性震颤患者中比较丘脑腹中间核(VIM)与后丘脑底区(PSA)脑深部电刺激的疗效与副作用。PSA与VIM在Fahn-Tolosa-Marin震颤评定量表总分改善上差异未达统计学显著(-7.4,95%CI -28.5至13.7,P=.328),但PSA在更低刺激强度下取得临床获益,且头部震颤、疾病特异性生活质量及言语和步态障碍方面更优。
要点
- PSA与VIM在FTM-TRS总分改善上差异未达统计学显著(-7.4,95%CI -28.5至13.7,P=.328)。
- PSA刺激在显著更低的刺激强度下即可获得临床获益。
- PSA较VIM在头部震颤子评分(-2.2,P=.020)和疾病特异性生活质量(-13.8,P=.046)改善更优。
核心结论
- PSA-DBS在抑制震颤方面与VIM-DBS相当,在改善疾病特异性生活质量方面更优,并可能更有效减少头部震颤。
研究设计与样本
- 随机双盲交叉试验,双侧植入单轨迹4触点DBS电极覆盖VIM和PSA。
- 术后随机分两组,分别先接受VIM刺激(4-7个月)再接受PSA刺激(8-11个月),或顺序相反。
- 共纳入10例药物难治性特发性震颤患者,9例完成研究。
- 主要终点为基线至VIM与PSA DBS期末FTM-TRS总分改善的差异。
主要发现
- PSA与VIM DBS期FTM-TRS总分降低的差异为-7.4(95%CI -28.5至13.7,P=.328)。
- PSA DBS在显著更低的刺激强度下取得临床获益。
- PSA较VIM在FTM-TRS头部震颤子评分改善更优(-2.2,P=.020)。
- PSA较VIM在疾病特异性生活质量改善更优(-13.8,P=.046)。
- PSA较VIM诱发的言语障碍更少(发声障碍严重程度指数评分P=.043;轮替运动速率P=.007;VDI评分P=.005)和步态障碍更少。
局限性
- 共纳入10例患者,9例完成研究,样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The thalamic ventral intermediate nucleus (VIM) is a well-established target for deep brain stimulation (DBS) in the treatment of essential tremor (ET). Increasing data indicate that the posterior subthalamic area (PSA) may be superior, but high-level evidence is limited. We aimed at further comparing the intraindividual efficacy and side effect profile of PSA vs VIM DBS in ET. METHODS: In this randomized, double-blind, crossover trial, 4-contact DBS leads were bilaterally implanted with single-trajectory covering the VIM and PSA. Patients were randomized postsurgery to 2 groups, receiving VIM stimulation (4-7 months) and then PSA stimulation (8-11 months) or vice versa. The primary end point was the difference in improvement from baseline to the end of the VIM vs PSA DBS period in the total score of the Fahn-Tolosa-Marin Tremor Rating Scale (FTM-TRS). RESULTS: Ten patients with medically refractory ET were enrolled, and 9 completed the study. The difference between reduction of FTM-TRS total score in the PSA vs VIM DBS period was -7.4 (95% CI: -28.5 to 13.7, P = .328). Clinical benefit was achieved at significantly lower stimulation intensity under PSA DBS. Furthermore, PSA DBS provided greater improvement in head tremor subscore of FTM-TRS (PSA vs VIM: -2.2, P = .020) and disease-specific quality of life (PSA vs VIM: -13.8, P = .046) and induced fewer speech (Dysphonia Severity Index score: P = .043; diadochokinetic rate: P = .007; VDI score: P = .005) and gait disturbances compared with VIM DBS. Seven patients remained with PSA DBS after the crossover phase. CONCLUSION: Our study confirms that PSA-DBS is comparable with VIM-DBS in suppressing tremors, superior in improving disease-specific quality of life, and possibly more effective in reducing head tremor.
引用
- Sun X, Shen R, Lin Z, et al. Optimizing Deep Brain Stimulation in Essential Tremor: A Randomized Controlled Trial for Target Consideration. Neurosurgery. 2024. PMID: 38270451. doi:10.1227/neu.0000000000002839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。